Fluvoxamine
Sold as Faverin, Fluvoxamine oethmaan, Fluvoxamine-hexal, Luvox
2-[(E)-[5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
Drag to rotate. Structure from PubChem CID 5324346.
Background
Registration
- Applicants
- 3
- Registrations
- 6
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Abbott Laboratories S.A. (Pty) LtdCertificate held by Abbott Laboratories South Africa (Pty) Ltd | Faverin, Luvox | 50, 100 mg | 330354, X0059, X0060 | S5 | PIPIL |
| Oethmaan Biosims (Pty) Ltd | Fluvoxamine oethmaan | 50, 100 | 360046, 360047 | S5 | None |
| Biotech Laboratories (Pty) Ltd | Fluvoxamine-hexal | 100 | 370102 | S5 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Faverin 100 EACH TABLET CONTAINS FLUVOXAMINE MALEATE 100,0 mg | 100 mg.Film-coated tablets | 33035433/1.2/0354Approved 13 February 2022 | Registered | S5 | PIPIL |
| Fluvoxamine oethmaan 50 EACH TABLET CONTAINS FLUVOXAMINE MALEATE 50,0 mg | 50 | 36004636/1.2/0046 | Registered | S5 | None |
| Fluvoxamine 100 oethmaan EACH TABLET CONTAINS FLUVOXAMINE MALEATE 100,0 mg | 100 | 36004736/1.2/0047 | Registered | S5 | None |
| Fluvoxamine-hexal 100 EACH TABLET CONTAINS FLUVOXAMINE MALEATE 100,0 mg | 100 | 37010237/1.2/0102 | Registered | S5 | None |
| Luvox 50 EACH TABLET CONTAINS FLUVOXAMINE MALEATE 50 mg | 50 | X0059X/1.2/59 | Registered | S5 | None |
| Luvox 100 EACH TABLET CONTAINS FLUVOXAMINE MALEATE 100 mg | 100 mg.Film-coated tablets. | X0060X/1.2/60Approved 13 February 2022 | Registered | S5 | PIPIL |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Fluvoxamine maleate
S5: Fluvoxamine
Consolidated Schedules 06 July 2026, line 9457
Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Faverin 100, Abbott Laboratories S.A. (Pty) Ltd is scheduled S5 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.